Literature DB >> 11913724

The pharmacogenetics of asthma: a candidate gene approach.

E S Silverman1, S B Liggett, E W Gelfand, L J Rosenwasser, R M Baron, S Bolk, S T Weiss, J M Drazen.   

Abstract

Mesh：

Substances：

Year:  2001        PMID： 11913724     DOI： 10.1038/sj.tpj.6500005

Source DB:  PubMed          Journal:  Pharmacogenomics J        ISSN： 1470-269X            Impact factor:   3.550


× No keyword cloud information.
  5 in total

1.  Influence of leukotriene pathway polymorphisms on response to montelukast in asthma.

Authors:  John J Lima; Shu Zhang; Audrey Grant; Lianhe Shao; Kelan G Tantisira; Hooman Allayee; Jianwei Wang; James Sylvester; Janet Holbrook; Robert Wise; Scott T Weiss; Kathleen Barnes
Journal:  Am J Respir Crit Care Med       Date:  2005-11-17       Impact factor: 21.405

2.  The Val34Met, Thr164Ile and Ser220Cys Polymorphisms of the β2-Adrenergic Receptor and Their Consequences on the Receptor Conformational Features: A Molecular Dynamics Simulation Study.

Authors:  Aneta Archala; Wojciech Plazinski; Anita Plazinska
Journal:  Int J Mol Sci       Date:  2022-05-13       Impact factor: 6.208

Review 3.  Treatment heterogeneity in asthma: genetics of response to leukotriene modifiers.

Authors:  John J Lima
Journal:  Mol Diagn Ther       Date:  2007       Impact factor: 4.074

4.  Antithetic regulation by beta-adrenergic receptors of Gq receptor signaling via phospholipase C underlies the airway beta-agonist paradox.

Authors:  Dennis W McGraw; Khalid F Almoosa; Richard J Paul; Brian K Kobilka; Stephen B Liggett
Journal:  J Clin Invest       Date:  2003-08       Impact factor: 14.808

5.  Antileukotriene reverts the early effects of inflammatory response of distal parenchyma in experimental chronic allergic inflammation.

Authors:  Nathália Brandão Gobbato; Flávia Castro Ribas de Souza; Stella Bruna Napolitano Fumagalli; Fernanda Degobbi Tenório Quirino Dos Santos Lopes; Carla Máximo Prado; Milton Arruda Martins; Iolanda de Fátima Lopes Calvo Tibério; Edna Aparecida Leick
Journal:  Biomed Res Int       Date:  2013-09-15       Impact factor: 3.411
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.